Best shampoos for hair loss can play a meaningful supporting role in scalp health, but choosing the right one depends on understanding what is driving your hair loss in the first place. From androgenetic alopecia and seborrhoeic dermatitis to telogen effluvium and scalp psoriasis, the underlying cause shapes which ingredients are most appropriate. This guide reviews the clinical evidence behind key shampoo actives available in the UK, explains how they work, and outlines when a shampoo alone is not enough — and when it is time to see your GP or a dermatologist.

What Causes Hair Loss and When to Seek Medical Advice

The most common cause of hair loss is androgenetic alopecia, driven by genetics and DHT, but causes also include telogen effluvium, alopecia areata, scalp conditions, nutritional deficiencies, and thyroid disorders. Seek GP advice if hair loss is sudden, patchy, inflamed, or accompanied by other symptoms.

Not sure if this is normal? Chat with one of our pharmacists →

Hair loss, known medically as alopecia, is a common condition affecting both men and women across all age groups. Understanding the underlying cause is essential before selecting any treatment, including specialist shampoos. The most prevalent form is androgenetic alopecia — often called male-pattern or female-pattern baldness — which is driven by genetic factors and the hormone dihydrotestosterone (DHT). Other common causes include:

• Telogen effluvium: a temporary shedding triggered by stress, illness, or hormonal changes such as postpartum hair loss. Postpartum shedding typically resolves on its own within 6–12 months without specific treatment.

• Alopecia areata: an autoimmune condition causing patchy hair loss

• Scalp conditions: such as seborrhoeic dermatitis, psoriasis, or fungal infections (tinea capitis). Tinea capitis predominantly affects children and requires prompt GP assessment, as systemic antifungal treatment is necessary and early intervention reduces the risk of transmission and scarring.

• Nutritional deficiencies: iron deficiency and low ferritin are the most clinically significant; vitamin D or B12 deficiency may also contribute in some individuals, though routine causal links are less well established

• Thyroid disorders: both hypothyroidism and hyperthyroidism can contribute to diffuse hair thinning

• Traction alopecia: caused by prolonged tension on the hair from tight hairstyles, extensions, or braids — a common and largely preventable cause that can lead to permanent follicle damage if not addressed early

It is important to recognise that hair loss is not always cosmetic — it can signal an underlying medical condition requiring investigation. If hair loss is sudden, patchy, accompanied by scalp inflammation, or associated with other symptoms such as fatigue or weight changes, prompt medical assessment is advisable. The NHS recommends seeking advice from a GP if hair loss is causing significant distress or if there is no obvious explanation, as early diagnosis can meaningfully improve outcomes. Further information is available from the NHS Hair Loss (Alopecia) page, NICE Clinical Knowledge Summaries (CKS) on alopecia, and the British Association of Dermatologists (BAD) patient information leaflets.

How Hair Loss Shampoos Work and What the Evidence Shows

Hair loss shampoos work by improving scalp health, reducing inflammation, and delivering active ingredients, but their rinse-off nature limits clinical efficacy compared with leave-on treatments. Ketoconazole shampoo has the strongest evidence; most other 'hair growth' shampoos are regulated as cosmetics with unverified efficacy claims.

Hair loss shampoos are topical products designed to create a healthier scalp environment, reduce inflammation, remove follicle-blocking sebum and product build-up, or deliver active ingredients that may support hair retention. It is important to set realistic expectations: shampoos are rinse-off products, meaning active ingredients have limited contact time with the scalp compared with leave-on treatments. This significantly affects their clinical efficacy.

The evidence base for hair loss shampoos varies considerably depending on the active ingredient. Ketoconazole shampoo has the most clinical data of any shampoo ingredient in this context. Some peer-reviewed studies suggest that 1–2% ketoconazole shampoo may improve scalp health and hair density in androgenetic alopecia, though these studies are generally small with methodological limitations and should not be interpreted as establishing parity with licensed leave-on therapies such as minoxidil. Ketoconazole's precise mechanism in androgenetic alopecia is not fully established; its primary licensed use is as an antifungal for seborrhoeic dermatitis and dandruff. In the UK, 1% ketoconazole shampoo is available over the counter; 2% is available from pharmacies and may also be prescribed. Per product labelling, ketoconazole shampoo is typically applied to the scalp, left for 3–5 minutes, then rinsed off, and used one to two times weekly for several weeks. Use should be stopped and medical advice sought if severe irritation occurs; check the product label for age restrictions and cautions in pregnancy or breastfeeding.

By contrast, many commercially marketed 'hair growth shampoos' rely on ingredients with limited or preliminary evidence — such as caffeine, biotin, or saw palmetto. Most such products are regulated as cosmetics under the UK Cosmetics Regulation rather than as medicines by the MHRA, meaning efficacy claims are not held to the same standard as licensed pharmaceutical products. Consumers should approach bold marketing claims with appropriate scepticism and prioritise products with published clinical data or those recommended by a healthcare professional.

Further guidance on medicated shampoos for scalp conditions is available from NICE CKS on seborrhoeic dermatitis and the BAD patient information leaflets.

Key Ingredients to Look for in Hair Loss Shampoos

Ketoconazole (1–2%), zinc pyrithione, selenium sulphide, and salicylic acid are the most evidence-informed ingredients in UK hair loss shampoos. Caffeine and saw palmetto have limited clinical trial data, and biotin is only beneficial if a genuine deficiency exists.

When evaluating shampoos for hair loss, focusing on evidence-informed ingredients is the most clinically sound approach. The following are among the most studied and widely available in the UK:

• Ketoconazole (1–2%): An antifungal agent with some evidence of benefit in seborrhoeic dermatitis and androgenetic alopecia. Its mechanism in hair loss is not fully established; claims that it directly reduces scalp DHT in vivo are based on limited data. It is best regarded as a scalp health aid rather than a standalone hair loss treatment. Available over the counter at 1% concentration.

• Zinc pyrithione: An antimicrobial and antifungal agent that helps manage dandruff and scalp inflammation, both of which can impair follicle health. Found in several widely available shampoos.

• Selenium sulphide: An antifungal agent effective for dandruff and seborrhoeic dermatitis; available in UK pharmacies.

• Piroctone olamine: An alternative antifungal active used in some anti-dandruff shampoos; may be suitable for those who do not tolerate other agents.

• Salicylic acid: A keratolytic agent that removes scale and unblocks follicles, particularly useful in scalp psoriasis or seborrhoeic dermatitis.

• Caffeine: Some in vitro (laboratory) studies suggest caffeine may counteract DHT-related follicle suppression, but robust clinical trial evidence in humans is limited. It should be regarded as a low-certainty option.

• Saw palmetto (Serenoa repens): A plant-derived DHT inhibitor. Most available evidence relates to oral supplementation; evidence for topical or shampoo formulations is very limited, and larger randomised controlled trials are needed before firm conclusions can be drawn.

• Biotin (vitamin B7): Commonly included in hair care products; however, biotin deficiency is rare in the UK, and supplementation is only likely to benefit those who are genuinely deficient. Importantly, the MHRA has warned that high-dose biotin supplementation can interfere with certain laboratory tests, including thyroid function and troponin assays. If you are taking biotin supplements, inform your clinician before any blood tests.

Ingredients such as niacinamide, panthenol, and amino acids may improve hair shaft condition and scalp hydration but are unlikely to address the root cause of hair loss directly.

Choosing a Suitable Shampoo for Your Hair Loss Type

The most appropriate shampoo depends on correctly identifying your hair loss type; ketoconazole suits androgenetic alopecia, while zinc pyrithione or selenium sulphide are preferred for dandruff-related loss. Suspected tinea capitis or scarring alopecia should not be managed with shampoo alone and require prompt medical assessment.

Selecting the most appropriate shampoo depends on correctly identifying the type and likely cause of your hair loss. A one-size-fits-all approach is rarely effective, and using the wrong product may provide no benefit or, in some cases, exacerbate scalp irritation.

For androgenetic alopecia (male- or female-pattern hair loss), ketoconazole shampoo has the most clinical support of any shampoo ingredient, primarily through its benefit to scalp health. Caffeine-based shampoos are a low-certainty option. These are best used as part of a broader treatment plan that may include topical minoxidil or, in men, finasteride — both discussed in the next section.

For seborrhoeic dermatitis or dandruff-related hair loss, shampoos containing ketoconazole, zinc pyrithione, selenium sulphide, piroctone olamine, coal tar, or salicylic acid are recommended. If one active ingredient does not help after a reasonable trial, switching to a product with a different active ingredient is a sensible approach. This is not about preventing resistance (as with antibiotics) but simply about finding what works best for your scalp.

For telogen effluvium, the priority is addressing the underlying trigger — whether nutritional, hormonal, or stress-related — rather than relying on shampoo alone. Gentle, sulphate-free formulations that minimise further mechanical damage are advisable during the recovery phase.

For scalp psoriasis, salicylic acid or coal tar shampoos can help manage scaling, though prescription treatments may be required for moderate-to-severe cases. Further advice is available from the NHS scalp psoriasis page and NICE CKS.

Suspected tinea capitis or scarring alopecia (such as lichen planopilaris or frontal fibrosing alopecia) should not be managed with shampoo alone. These conditions require prompt medical assessment and, in most cases, systemic or prescription therapy. Scarring alopecias in particular warrant expedited dermatology referral, as permanent follicle loss can occur if treatment is delayed.

It is worth noting that hair type and texture also matter. Those with afro-textured or chemically treated hair should seek products specifically formulated for their hair type, as some medicated shampoos can cause excessive dryness or breakage if used without appropriate conditioning. Always follow medicated shampoo use with a suitable conditioner, and reduce frequency if excessive dryness occurs.

Other Treatments Available for Hair Loss on the NHS

Topical minoxidil is an MHRA-licensed over-the-counter treatment for androgenetic alopecia, while finasteride is a prescription-only option for men not routinely available on the NHS. JAK inhibitors baricitinib and ritlecitinib are MHRA-licensed for severe alopecia areata and require specialist initiation.

Shampoos alone are rarely sufficient to halt or reverse significant hair loss. A range of additional treatments are available, some of which are accessible through the NHS depending on the underlying diagnosis.

Topical minoxidil (available as Regaine and generic equivalents in the UK) is one of the few MHRA-licensed, over-the-counter treatments for androgenetic alopecia. It is available as a 2% or 5% solution or foam. Its precise mechanism is not fully understood; it is thought to prolong the anagen (growth) phase of the hair cycle. Consistent, long-term use is required to maintain results — hair loss typically returns if treatment is stopped. Common side effects include scalp irritation and, occasionally, unwanted facial hair growth. Check the patient information leaflet for full cautions, including advice in pregnancy and breastfeeding.

Experiencing these side effects? Our pharmacists can help you navigate them →

Finasteride (1 mg tablets) is a prescription-only oral DHT inhibitor licensed for male-pattern baldness in men. It is not routinely available on the NHS for hair loss and is typically obtained via a private prescription — this reflects NHS prescribing policy rather than a specific NICE recommendation. Finasteride is contraindicated in pregnancy due to teratogenic risk and should not be handled by women who are or may become pregnant. The MHRA has issued safety warnings regarding finasteride, including risks of sexual dysfunction (which may persist after stopping treatment), mood changes, and suicidal ideation. Patients should be counselled about these risks before starting treatment and should seek prompt medical review if they experience any of these effects. Further information is available from the MHRA Drug Safety Update on finasteride and the electronic Medicines Compendium (emc) SmPC.

Corticosteroids — topical, intralesional, or systemic — are used in alopecia areata and inflammatory scalp conditions, and may be prescribed by a GP or dermatologist.

Immunotherapy (diphencyprone) and JAK inhibitors represent newer options for severe alopecia areata. Both baricitinib (Olumiant) and ritlecitinib (Litfulo) are MHRA-licensed for severe alopecia areata; ritlecitinib is licensed for use in patients aged 12 years and over. These treatments are specialist-initiated and access may be subject to local commissioning policies and NICE technology appraisal criteria. Referral to a specialist dermatology service is required.

The NHS also provides access to wigs and hairpieces for patients with certain medical conditions causing hair loss, such as alopecia areata or chemotherapy-related hair loss, subject to local commissioning policies. Further information is available on the NHS Wigs and Fabric Supports page.

If you experience a suspected side effect from any medicine, you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

When to See a GP or Dermatologist About Hair Loss

See your GP if hair loss is sudden, patchy, inflamed, or accompanied by systemic symptoms, or if there is no improvement after three to six months of self-treatment. Scarring alopecia and suspected tinea capitis warrant prompt or expedited referral to prevent permanent follicle damage.

Whilst many cases of hair loss are benign and self-limiting, there are clear clinical situations in which professional assessment is warranted. Relying solely on over-the-counter shampoos without seeking a diagnosis risks delaying treatment for potentially treatable or medically significant conditions.

You should contact your GP if you experience:

• Sudden or rapid hair loss over a short period

• Patchy or irregular hair loss rather than diffuse thinning

• Scalp redness, scaling, itching, or pain

• Hair loss accompanied by systemic symptoms such as fatigue, weight changes, or irregular periods

• Signs of hyperandrogenism such as acne or increased facial or body hair, which may indicate an underlying hormonal condition such as polycystic ovary syndrome (PCOS)

• Hair loss beginning in childhood or adolescence

• Suspected traction alopecia from tight hairstyles or extensions — early intervention can prevent permanent damage

• No improvement after three to six months of appropriate self-treatment

Your GP may arrange blood tests to investigate potential causes. Investigations are tailored to the clinical picture and may include full blood count, ferritin, thyroid function tests, and — where malabsorption is suspected — a coeliac screen. Vitamin D and B12 are measured selectively based on clinical indication. If an underlying condition is identified, treating it directly is likely to be more effective than any topical shampoo.

Referral to a consultant dermatologist may be appropriate for complex or treatment-resistant cases. Suspected scarring alopecia (such as lichen planopilaris or frontal fibrosing alopecia) warrants prompt or expedited referral, as permanent follicle destruction can occur if treatment is delayed. Suspected tinea capitis, particularly in children, also requires prompt GP assessment and systemic antifungal treatment; early treatment reduces the risk of transmission and scarring.

Further guidance on assessment and referral is available from NICE CKS on alopecia and tinea capitis, and from BAD patient information leaflets on scarring alopecia and androgenetic alopecia.

In summary, hair loss shampoos can play a supportive role in scalp health and, in some cases, hair retention — but they are most effective when used as part of a clinically informed, holistic approach to hair loss management.

Frequently Asked Questions